The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review
Open accessAbstract
Despite on-going evolution and iteration of drug-eluting stent (DES) technology, the prevalence of in-stent restenosis (ISR) remains relatively unchanged, encompassing ≈10% of percutaneous coronary interventions. The mechanism of ISR is multifactorial, including biological, mechanical, patient, and operator-related factors. The main mechanical contributors are stent underexpansion or fracture, while biological factors include local inflammation leading to aggressive neointimal proliferation and late neoatherosclerosis. Intracoronary imaging is critical to identify the mechanism of ISR and tailor therapy accordingly. The presentation of DES-ISR is not benign and is challenging for optimal treatment. Among the proposed treatment modalities are scoring and high-pressure balloons, percutaneous coronary intervention with additional DES, atheroablative therapies by laser or mechanical atherectomy, drug-coated balloons, vascular brachytherapy, and surgical revascularization. We propose a new classification for ISR that differentiates among mechanical, biological, and mixed etiologies. Stratifying ISR by mechanism guides individualized treatment of DES-ISR to improve clinical outcomes. An algorithmic approach, guided by intracoronary imaging, for the treatment of DES-ISR, is recommended based on the specific cause of restenosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
Angiographic Patterns of In-Stent Restenosis: Classification and Implications for Long-Term Outcome
Mehran, R., Dangas, G., Abizaid, A. S., Mintz, G. S., Lansky, A. J., Satler, L. F., Pichard, A. D., Kent, K. M., Stone, G. W., & Leon, M. B. (1999) · Circulation · doi:10.1161/01.cir.100.18.1872 · Cited by 1,258
Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M., & Karnabatidis, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011245 · Cited by 1,020
Kastrati, A., Mehilli, J., von Beckerath, N., Dibra, A., Hausleiter, J., Pache, J., Schühlen, H., Schmitt, C., Dirschinger, J., Schömig, A., et al. (2005) · JAMA · doi:10.1001/jama.293.2.165 · Cited by 605
Current Treatment of In-Stent Restenosis
Alfonso, F., Byrne, R. A., Rivero, F., & Kastrati, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.545 · Cited by 577
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
Bønaa, K. H., Mannsverk, J., Wiseth, R., Aaberge, L., Myreng, Y., Nygård, O., Nilsen, D. W., Kløw, N.-E., Uchto, M., Trovik, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607991 · Cited by 553
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
Cutlip, D. E., Chhabra, A. G., Baim, D. S., Chauhan, M. S., Marulkar, S., Massaro, J., Bakhai, A., Cohen, D. J., Kuntz, R. E., & Ho, K. K. L. (2004) · Circulation · doi:10.1161/01.cir.0000140721.27004.4b · Cited by 302
Lemos, P. A., Saia, F., Ligthart, J. M. R., Arampatzis, C. A., Sianos, G., Tanabe, K., Hoye, A., Degertekin, M., Daemen, J., McFadden, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083366.33686.11 · Cited by 286
Cited by
Giustino, G., Colombo, A., Camaj, A., Yasumura, K., Mehran, R., Stone, G. W., Kini, A., & Sharma, S. K. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.05.017 · Cited by 413
Rahvar, M., Ahmadi Lakalayeh, G., Nazeri, N., Marouf, B. T., Shirzad, M., Najafi T. Shabankareh, A., & Ghanbari, H. (2021) · Biomedical Engineering Letters · doi:10.1007/s13534-021-00205-9 · Cited by 15
Metadata
- Authors
- Shlofmitz, E., Iantorno, M., & Waksman, R.
- Venue
- Circulation: Cardiovascular Interventions
- Published
- 2019-08
- Volume
- 12
- Issue
- 8
- Pages
- e007023-e007023
- ISSN
- 1941-7632 (ISSN-L)
- 1941-7640
- OpenAlex
- W2966389726
- Cited by
- 289
- References
- 17
- FWCI
- 22.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. https://app.cochat.ai/papers/10.1161/circinterventions.118.007023
- The paper
- Shlofmitz, E., Iantorno, M., & Waksman, R. (2019). Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.118.007023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.